Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
about
Extrahepatic cancer suppresses nuclear receptor-regulated drug metabolism.Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy.Inflammation and cancer: causes and consequences.Use of inflammatory markers to guide cancer treatment.Signs and symptoms of rheumatic diseases as first manifestation of pediatric cancer: diagnosis and prognosis implications.
P2860
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inflammatory (B) symptoms are ...... al comparing CHOP to PMitCEBO.
@ast
Inflammatory (B) symptoms are ...... al comparing CHOP to PMitCEBO.
@en
type
label
Inflammatory (B) symptoms are ...... al comparing CHOP to PMitCEBO.
@ast
Inflammatory (B) symptoms are ...... al comparing CHOP to PMitCEBO.
@en
prefLabel
Inflammatory (B) symptoms are ...... al comparing CHOP to PMitCEBO.
@ast
Inflammatory (B) symptoms are ...... al comparing CHOP to PMitCEBO.
@en
P2093
P2860
P356
P1433
P1476
Inflammatory (B) symptoms are ...... al comparing CHOP to PMitCEBO.
@en
P2093
Graham Robertson
Paul Smith
Rohini Sharma
Stephen J Clarke
P2860
P2888
P356
10.1186/1471-2407-9-153
P407
P577
2009-05-18T00:00:00Z
P5875
P6179
1018395442